Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial - Matthews, D R; Paldánius, P M; Proot, P; VERIFY study group (Lancet, 2019)
et al.